0.8281
Context Therapeutics Inc Azioni (CNTX) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Operating Income/Loss |
76.49%
-9.7584
|
-5.5291 | -4.3104 | -18.70 | -3.0885 |
Income/Loss From Continuing Operations Before Tax |
92.86%
-8.8275
|
-4.5773 | -28.96 | 1.2437 | -2.2545 |
Income/Loss From Continuing Operations After Tax |
92.86%
-8.8275
|
-4.5773 | -3.3429 | -17.46 | -2.2545 |
|
92.86%
-8.8275
|
-4.5773 | -3.3429 | -17.46 | -2.2545 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.00%
95.19
|
95.19 | 7.838 | 80.48 | 54.96 |
Diluted Average Shares |
0.00%
95.19
|
95.19 | 7.838 | 80.48 | 54.96 |
Basic Earnings Per Share |
80.00%
-0.09
|
-0.05 | - | -0.22 | -0.04 |
Diluted Earnings Per Share |
80.00%
-0.09
|
-0.05 | - | -0.22 | -0.04 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):